Search results
Illinois public officials seek greater oversight of prescription drug 'middlemen'
ABC 7 Chicago· 20 hours agoOften referred to as pharmaceutical "middlemen," PBMs act as third-party intermediaries who...
GoodRx (GDRX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 18 minutes agoWe've done this through our integrated savings program, or ISP, with PBM partners like CVS Caremark, Express Scripts, MedImpact and Navitus, who...
SHP report claims hospitals overcharging for oncology drugs
Winston-Salem Journal· 11 hours agoThe program, known as 340B, was created by Congress in 1992 to financially assist hospitals serving...
A Kensington pharmacy’s closure after 26 years highlights the industry’s growing challenges
Philly.com· 2 days agoLast Monday, Friendly Pharmacy filled 318 prescriptions. For about 100 of them, insurance companies...
...MEMBERS: A Class Action Lawsuit Has Been Filed Against CVS Health Corporation and Related...
FOX 59 Indianapolis· 6 days ago...Check, LLP and Carella, Byrne, Cecchi, Brody & Agnello, P.C. inform current and former...
'Total fear:' Local families describe struggle to find needed medications as shortages hit peak
Springfield News-Sun, Ohio via Yahoo News· 2 days agoMay 7—The number of drugs in shortage reached a record high this year and has pushed some local families to spend hours calling multiple pharmacies to try to find the medication, or even ration ...
Medicare Advantage pluses could be cut in 2025
Consumer Affairs· 2 days agoIf you’re a Medicare Advantage plan holder, your “advantages” could be a little less the next time you renew because insurers are planning to cut back on...
Draft rule requiring pharmacy payments hits roadblock - Talk Business & Politics
Talk Business & Politics· 7 days agoA draft Arkansas Insurance Department rule that would have required pharmacy benefit managers to...
Earnings call: Amneal Pharmaceuticals sees robust growth in Q1 2024 By Investing.com
Investing.com· 6 days agoThis growth was fueled by double-digit increases across all segments—Generics, Specialty, and...